HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mitchell C Posner Selected Research
Mitchell C Posner Research Topics
Disease
47
Neoplasms (Cancer)
11/2023 - 01/2002
19
Neoplasm Metastasis (Metastasis)
01/2023 - 07/2002
13
Adenocarcinoma
12/2022 - 08/2002
6
Esophageal Neoplasms (Esophageal Cancer)
10/2016 - 02/2008
4
Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 12/2006
4
Stomach Neoplasms (Stomach Cancer)
08/2021 - 05/2010
4
Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 02/2011
3
Colonic Neoplasms (Colon Cancer)
01/2020 - 08/2002
3
Rectal Neoplasms (Rectal Cancer)
01/2019 - 10/2005
3
Carcinoma (Carcinomatosis)
12/2011 - 09/2004
2
Hypoxia (Hypoxemia)
11/2023 - 01/2003
2
Carcinogenesis
11/2023 - 12/2012
2
Margins of Excision
04/2014 - 10/2005
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2007 - 09/2005
2
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2007 - 10/2003
1
Aggressive Fibromatosis (Desmoid)
11/2023
1
Fibroma (Fibromatosis)
11/2023
1
Hypersensitivity (Allergy)
10/2022
1
COVID-19
08/2020
1
Lung Neoplasms (Lung Cancer)
01/2018
1
Liver Diseases (Liver Disease)
01/2017
1
Cholangiocarcinoma
07/2015
1
Chronic Pancreatitis
04/2015
1
Breast Neoplasms (Breast Cancer)
02/2015
1
Neutropenia
12/2011
1
Vomiting
12/2011
1
Prostatic Neoplasms (Prostate Cancer)
07/2011
1
Melanoma (Melanoma, Malignant)
03/2011
Drug/Important Bio-Agent (IBA)
6
MicroRNAs (MicroRNA)
IBA
01/2023 - 01/2011
5
DNA (Deoxyribonucleic Acid)
IBA
10/2022 - 05/2004
4
Proteins (Proteins, Gene)
FDA Link
11/2023 - 06/2002
4
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2013
4
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2013 - 10/2003
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2007 - 06/2002
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2023 - 02/2012
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2007 - 02/2006
2
Nucleic Acids
IBA
12/2022 - 01/2022
2
Deoxyribose
IBA
12/2022 - 01/2022
2
Cell-Free Nucleic Acids
IBA
01/2022 - 01/2018
2
Antibodies
IBA
01/2021 - 01/2018
2
tdTomato
IBA
11/2016 - 06/2015
2
Luciferases
IBA
11/2016 - 06/2015
2
Vaccines
IBA
07/2016 - 01/2008
2
Antigens
IBA
07/2016 - 01/2008
2
Indicators and Reagents (Reagents)
IBA
02/2016 - 04/2014
2
Doxorubicin (Adriamycin)
FDA Link
Generic
06/2009 - 09/2004
2
Monoclonal Antibodies
IBA
01/2008 - 01/2002
2
Imatinib Mesylate (Gleevec)
FDA Link
06/2007 - 10/2003
2
Complementary DNA (cDNA)
IBA
01/2003 - 08/2002
1
Catenins
IBA
11/2023
1
Becaplermin (PDGF-BB)
FDA Link
11/2023
1
Sorafenib (BAY 43-9006)
FDA Link
11/2023
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2023
1
Fluorouracil (Carac)
FDA Link
Generic
01/2023
1
Cetuximab (Erbitux)
FDA Link
01/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
01/2023
1
Circulating Tumor DNA
IBA
01/2022
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2022
1
4-hydroxyacetophenone
IBA
01/2020
1
Trastuzumab (Herceptin)
FDA Link
01/2020
1
Antral
IBA
01/2020
1
Actomyosin
IBA
01/2020
1
Decitabine
FDA Link
01/2019
1
Methyltransferases
IBA
01/2019
1
fedratinib
IBA
01/2018
1
Cytotoxins (Cytolysins)
IBA
01/2017
1
Polymers
IBA
01/2017
1
Platinum
IBA
01/2017
1
Therapeutic Uses
IBA
01/2017
1
Chemokines
IBA
07/2016
1
superagonist SIYR
IBA
07/2016
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2013
1
Phosphotransferases (Kinase)
IBA
01/2013
1
Capecitabine (Xeloda)
FDA Link
02/2012
1
Docetaxel (Taxotere)
FDA Link
12/2011
1
veliparib
IBA
07/2011
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
07/2011
Therapy/Procedure
27
Therapeutics
11/2023 - 03/2004
9
Drug Therapy (Chemotherapy)
01/2023 - 01/2003
7
Esophagectomy
10/2016 - 04/2005
6
Neoadjuvant Therapy
01/2019 - 02/2012
5
Radiotherapy
12/2020 - 06/2002
3
Induction Chemotherapy
01/2022 - 12/2011
3
Metastasectomy
08/2021 - 07/2002
3
Immunotherapy
07/2016 - 01/2008
2
Aftercare (After-Treatment)
11/2023 - 07/2011
2
Pancreaticoduodenectomy
12/2019 - 05/2014
2
Pancreatectomy
01/2019 - 08/2013
2
Autologous Transplantation
01/2019 - 04/2015
2
Lymph Node Excision (Lymph Node Dissection)
01/2016 - 05/2010
2
Chemoradiotherapy
12/2013 - 12/2011
2
Minimally Invasive Surgical Procedures
12/2012 - 03/2002
2
Contraindications
08/2003 - 07/2002
1
Cytoreduction Surgical Procedures
08/2021
1
Gastrectomy
08/2021
1
Operative Surgical Procedures
08/2020
1
Precision Medicine
01/2018
1
Splenectomy
11/2016
1
Perioperative Period
03/2011